Product News
Abbott’s ID NOW COVID-19 rapid test shows strong agreement to PCR instruments
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Enabling new synthetic biology applications including protein production and the engineering of bacteria
Discover the latest tools and techniques to support your laboratory workflows with expert-led presentations in cutting edge biopharmaceuticals research
The combined solution aims to enable researchers to reproducibly prepare samples of all types for mass spectrometry-based proteomics
Discover the benefits of new technology and method development strategies for new techniques
High Throughput Data Independent Approach for Qualitative and Quantitative Lipidomic Analysis